Evidence‐Based Nursing Management During Mavacamten Therapy in an 89‐Year‐Old Patient With Symptomatic Hypertrophic Obstructive Cardiomyopathy: A Case Report
ABSTRACT In older patients receiving mavacamten, a reduction in NT‐proBNP levels may coexist with persistent severe LVOTO. Nurses should interpret this biomarker–echocardiography discordance as a safety signal and maintain structured cardiovascular surveillance rather than assuming treatment success based solely on biomarker improvement.
Authors
- Feifei Wang (ORCID: https://orcid.org/0009-0000-5936-8094)
Institutions
- Guangdong Academy of Medical Sciences (CN)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2026-07-30
- DOI
- https://doi.org/10.1002/ccr3.73171
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00